Ningbo Menovo Pharmaceutical Co (SHSE:603538) Accounts Payable & Accrued Expense : ¥671 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ningbo Menovo Pharmaceutical Co Accounts Payable & Accrued Expense?

Ningbo Menovo Pharmaceutical Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (¥686 Mil) to Dec. 2024 (¥755 Mil) but then declined from Dec. 2024 (¥755 Mil) to Mar. 2025 (¥671 Mil).

Ningbo Menovo Pharmaceutical Co's annual accounts payable & accrued expense increased from Dec. 2022 (¥655 Mil) to Dec. 2023 (¥657 Mil) and increased from Dec. 2023 (¥657 Mil) to Dec. 2024 (¥755 Mil).

Ningbo Menovo Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ningbo Menovo Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ningbo Menovo Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Ningbo Menovo Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

441.71

556.83

655.08

656.83

754.51

Ningbo Menovo Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															567.25	656.58	686.39	754.51	671.30

Ningbo Menovo Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ningbo Menovo Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ningbo Menovo Pharmaceutical Co Ltd (SHSE:603538) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

No.999,Yangfan Road, Room 1406, No.1, High-tech Zone, Ningbo, CHN, 315040

Website

http://www.menovopharm.com

Ningbo Menovo Pharmaceutical Co Ltd is a China-based company is engaged in the research and development, pilot, production and sales of pharmaceutical intermediates, APIs and finished drugs. Its products line includes cardiovascular, central nervous, respiratory, anti-tumor, anti-infective, digestive system, geriatric diseases and anti-viral systems.

Executives

Xu Jian	senior management
Cao Qian	Director
Yao Fang	Director
Ying Gao Feng	Director
Sun Yan	Director
Shi Jian Xiang	Director
Wu Feng Yun	Director
Tu Ying	Director
Yao Cheng Zhi	Director
Zheng Hui Lin	Supervisors
Jiao Hua	senior management

Ningbo Menovo Pharmaceutical Co Headlines

No Headlines